Long-Term Safety of Elagolix With Add-Back in Women With Endometriosis-Associated Pain: 36-Month Results

被引:0
|
作者
Simon, James [1 ]
Kim, Jin Hee [1 ]
Miller, Paul [1 ]
Ng, Juki [1 ]
Snabes, Michael [1 ]
Thomas, James [1 ]
机构
[1] George Washington Univ, Washington, DC USA
来源
OBSTETRICS AND GYNECOLOGY | 2023年 / 141卷
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
1368036
引用
收藏
页码:13S / 13S
页数:1
相关论文
共 50 条
  • [31] Long-term outcome of nonconservative surgery (hysterectomy) for endometriosis-associated pain in women <30 years old -: Discussion
    Malinak, R
    Ansbacher, R
    Beck, E
    Wagner, SR
    MacDonald, SR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (06) : 1362 - 1363
  • [32] Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain
    Leyland, Nicholas
    Taylor, Hugh S.
    Archer, David F.
    Peloso, Paul M.
    Soliman, Ahmed M.
    Palac, Hannah L.
    Martinez, Marisol
    Abrao, Mauricio S.
    JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2019, 11 (04) : 171 - 180
  • [33] Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain
    Caruso, Salvatore
    Iraci, Marco
    Cianci, Stefano
    Vitale, Salvatore Giovanni
    Fava, Valentina
    Cianci, Antonio
    JOURNAL OF PAIN RESEARCH, 2019, 12 : 2371 - 2378
  • [34] Baseline endometriosis-associated pain burden: Data from 1600+ women enrolled in elagolix clinical trials
    Leyland, Nicholas
    Estes, Stephanie J.
    Eichner, Samantha
    Soliman, Ahmed M.
    Mai, Yabing
    Snabes, Michael C.
    Taylor, Hugh S.
    Surrey, Eric S.
    JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2019, 11 (03) : 117 - 125
  • [35] Long-Term Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines: Results From a 36-Month, Multicenter, Open-Label Extension Study
    Schlessinger, Joel
    Dover, Jeffrey S.
    Joseph, John
    Monheit, Gary
    Nelson, Diane B.
    Albright, Craig D.
    Axford-Gatley, Robert A.
    Cohen, Joel L.
    DERMATOLOGIC SURGERY, 2014, 40 (02) : 176 - 183
  • [36] Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids
    Thomas, EJ
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 : 18 - 21
  • [37] ELAGOLIX REDUCED DYSPAREUNIA AND IMPROVED HEALTH-RELATED QUALITY OF LIFE IN PREMENOPAUSAL WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN.
    Leyland, N.
    Taylor, H. S.
    Archer, D. F.
    Peloso, P. M.
    Schwefel, B.
    Soliman, A. M.
    Martinez, M.
    Abrao, M. S.
    FERTILITY AND STERILITY, 2018, 110 (04) : E82 - E83
  • [38] Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist: results from a phase 2, randomized controlled study
    Acs, Nandor
    O'Brien, Chris
    Jiang, Ping
    Burke, Joshua
    Jimenez, Roland
    Garner, Elizabeth
    Chwalisz, Kristof
    JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2015, 7 (02) : 56 - 62
  • [39] REDUCTIONS IN ENDOMETRIOSIS-ASSOCIATED PAIN AMONG ELAGOLIX-TREATED WOMEN ARE CONSISTENT ACROSS A RANGE OF BASELINE CHARACTERISTICS.
    Singh, S.
    Lessey, B. A.
    Martinez, M.
    Peloso, P.
    Schwefel, B.
    Surrey, E.
    Taylor, H. S.
    FERTILITY AND STERILITY, 2018, 110 (04) : E84 - E85
  • [40] Endometriosis-associated intestinal tumours: a consequence of long-term unopposed oestrogen?
    Efthymiou, Christopher A.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2009, 91 (03) : 259 - 260